Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy.

Sheng YL, Chen X, Hou XO, Xin-Yuan, Yuan BS, Yuan YQ, Zhang QL, Cao X, Liu CF, Luo WF, Hu LF.

Exp Neurol. 2017 Aug 15. pii: S0014-4886(17)30212-1. doi: 10.1016/j.expneurol.2017.08.007. [Epub ahead of print]

PMID:
28821398
2.

Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 3: Treatment.

Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P.

Z Gerontol Geriatr. 2017 Feb 28. doi: 10.1007/s00391-017-1199-1. [Epub ahead of print] Review.

PMID:
28246893
3.

Elevated Cystatin C Levels Are Associated with Cognitive Impairment and Progression of Parkinson Disease.

Hu WD, Chen J, Mao CJ, Feng P, Yang YP, Luo WF, Liu CF.

Cogn Behav Neurol. 2016 Sep;29(3):144-9. doi: 10.1097/WNN.0000000000000100.

PMID:
27662452
4.

The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.

Vieru E, Köksal A, Mutluay B, Dirican AC, Altunkaynak Y, Baybas S.

Neurol Sci. 2016 May;37(5):743-7. doi: 10.1007/s10072-015-2471-z. Epub 2016 Jan 11.

PMID:
26753800
5.

Genome-wide variant by serum urate interaction in Parkinson's disease.

Nazeri A, Roostaei T, Sadaghiani S, Chakravarty MM, Eberly S, Lang AE, Voineskos AN.

Ann Neurol. 2015 Nov;78(5):731-41. doi: 10.1002/ana.24504. Epub 2015 Aug 29.

PMID:
26284320
6.

Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson's disease.

Jitkritsadakul O, Jagota P, Bhidayasiri R.

Parkinsonism Relat Disord. 2015 Jan;21(1):61-7. doi: 10.1016/j.parkreldis.2014.11.003. Epub 2014 Nov 12.

PMID:
25466402
7.

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

Kim TH, Lee JH.

PLoS One. 2014 Nov 11;9(11):e112512. doi: 10.1371/journal.pone.0112512. eCollection 2014.

8.

Synthesis of short graphene oxide nanoribbons for improved biomarker detection of Parkinson's disease.

Sun CL, Su CH, Wu JJ.

Biosens Bioelectron. 2015 May 15;67:327-33. doi: 10.1016/j.bios.2014.08.046. Epub 2014 Aug 23.

PMID:
25201013
9.

[Preliminary relationship between serum cystatin C level and Parkinson's disease].

Xu J, Chen J, Mao C, Yang Y, Liu C.

Zhonghua Yi Xue Za Zhi. 2014 Mar 25;94(11):804-7. Chinese.

PMID:
24854744
10.

Serum uric acid and risk of dementia in Parkinson's disease.

González-Aramburu I, Sánchez-Juan P, Sierra M, Fernández-Juan E, Sánchez-Quintana C, Berciano J, Combarros O, Infante J.

Parkinsonism Relat Disord. 2014 Jun;20(6):637-9. doi: 10.1016/j.parkreldis.2014.02.023. Epub 2014 Mar 5.

PMID:
24637121
11.

ZnO nanowire arrays on 3D hierachical graphene foam: biomarker detection of Parkinson's disease.

Yue HY, Huang S, Chang J, Heo C, Yao F, Adhikari S, Gunes F, Liu LC, Lee TH, Oh ES, Li B, Zhang JJ, Huy TQ, Luan NV, Lee YH.

ACS Nano. 2014 Feb 25;8(2):1639-46. doi: 10.1021/nn405961p. Epub 2014 Jan 13.

PMID:
24405012
12.

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

Parkinson Study Group SURE-PD Investigators, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K.

JAMA Neurol. 2014 Feb;71(2):141-50. doi: 10.1001/jamaneurol.2013.5528.

13.

Serum urate and the risk of Parkinson's disease: results from a meta-analysis.

Shen C, Guo Y, Luo W, Lin C, Ding M.

Can J Neurol Sci. 2013 Jan;40(1):73-9.

PMID:
23250131
14.

Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: a cross-sectional study.

Pan M, Gao H, Long L, Xu Y, Liu M, Zou J, Wu A, Wei X, Chen X, Tang B, Wang Q.

Neuroimmunomodulation. 2013;20(1):19-28. doi: 10.1159/000342483. Epub 2012 Nov 14.

PMID:
23154271
15.

Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.

Sun CC, Luo FF, Wei L, Lei M, Li GF, Liu ZL, LE WD, Xu PY.

Chin Med J (Engl). 2012 Feb;125(4):583-7.

PMID:
22490478
16.

Lower serum UA levels in Parkinson's disease patients in the Chinese population.

Zhang HN, Guo JF, He D, Lei LF, Wang YQ, Wang CY, Tan LM, Yan XX, Shen L, Tang BS.

Neurosci Lett. 2012 Apr 18;514(2):152-5. doi: 10.1016/j.neulet.2012.02.077. Epub 2012 Mar 3.

PMID:
22405811
17.

Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

Schwarzschild MA, Marek K, Eberly S, Oakes D, Shoulson I, Jennings D, Seibyl J, Ascherio A; Parkinson Study Group PRECEPT Investigators.

Mov Disord. 2011 Aug 15;26(10):1864-8. doi: 10.1002/mds.23741. Epub 2011 Apr 29.

18.

Uric acid and cognition in Parkinson's disease: a follow-up study.

Annanmaki T, Pohja M, Parviainen T, Hakkinen P, Murros K.

Parkinsonism Relat Disord. 2011 Jun;17(5):333-7. doi: 10.1016/j.parkreldis.2011.01.013. Epub 2011 Feb 12.

PMID:
21320793
19.

Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.

Winquist A, Steenland K, Shankar A.

Mov Disord. 2010 May 15;25(7):932-6. doi: 10.1002/mds.23070.

PMID:
20310031
20.

[Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].

Wang XJ, Luo WF, Wang LJ, Mao CJ, Wang L, Liu CF.

Zhonghua Yi Xue Za Zhi. 2009 Jun 16;89(23):1633-5. Chinese.

PMID:
19957513

Supplemental Content

Loading ...
Support Center